Retraction

Roxithromycin Inhibits the Effector Phase of Delayed-type Hypersensitivity

Paper Information

Retraction Details

Retraction Reason:

Plagiarism of Article

Nature of Retraction:

Retraction

Citations (6)

6
Total Citations
4
Post-Retraction
(66.7%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
3 After 2+ years
1908 Days since retraction (latest)
Paper citing Roxithromycin Inhibits the Effector Phase of Delay...
Unknown Authors
Unknown Journal
Published: Jan 2016
1908 days after retraction
Paper citing Roxithromycin Inhibits the Effector Phase of Delay...
Unknown Authors
Unknown Journal
Published: Feb 2015
1553 days after retraction
Paper citing Pharmacokinetic interaction of paeoniflorin and si...
Unknown Authors
Unknown Journal
Published: Oct 2013
1069 days after retraction
Paper citing Roxithromycin Inhibits the Effector Phase of Delay...
Unknown Authors
Unknown Journal
Published: Apr 2011
156 days after retraction
Paper citing Uncoupling IL-2 signals that regulate T cell proli...
Unknown Authors
Unknown Journal
Published: Dec 2009
335 days before retraction
Paper citing Roxithromycin Inhibits the Effector Phase of Delay...
Unknown Authors
Unknown Journal
Published: Jun 2009
514 days before retraction
Quick Stats
Total Citations: 6
Years Since Retraction: 15.1 years
Open Access: Yes
Last Checked: Never
Related Papers
Methyl helicterilate ameliorates alcohol-induced hepatic fi…
International Immunopharmacology • 13 citations
Modulation of cytokine and β-defensin 2 expressions in huma…
International Immunopharmacology • 25 citations
Cyanorona-20: The first potent anti-SARS-CoV-2 agent
International Immunopharmacology • 28 citations
Oroxylin A inhibits carcinogen-induced skin tumorigenesis t…
International Immunopharmacology • 24 citations
MiR-92b-3p ameliorates inflammation and autophagy by target…
International Immunopharmacology • 24 citations